13F Data
13F filer · CIK 2111120

MWG Caph Ltd

WASHINGTON, DC · filing since Q4 2025 · last filing Feb 17, 2026
Reported value
$72.4M
Positions
3
New / sold out
3 / 0
Added / reduced
0 / 0
Turnover
–
buys $72.4M · sells $0
Top-10 weight
100.0%

No 13F for Q3 2025, so every position this quarter shows as new.

Biggest buys vs Q3 2025

ChangeSecurityShares changeChange %Est. trade value
NewBEAM THERAPEUTICS INC+1,266,934–+$35.1M
NewLYELL IMMUNOPHARMA INC+1,008,116–+$31.0M
NewPRIME MEDICINE INC+1,792,210–+$6.2M

Biggest sells vs Q3 2025

No reduced or sold positions this quarter.

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q4 2025: $72.4M
Q4 2025Q4 2025

Holdings · Q4 2025

#SecuritySharesValueWeight
1BEAM THERAPEUTICS INCCOM1,266,934$35.1M48.53%
2LYELL IMMUNOPHARMA INCCOM NEW1,008,116$31.0M42.88%
3PRIME MEDICINE INCCOM1,792,210$6.2M8.59%